Genetic Variations in MicroRNA-related Genes Are Associated with Survival and Recurrence in Patients with Renal Cell Carcinoma

Overview

Journal Carcinogenesis

Specialty Oncology

Date 2010 Aug 25

PMID 20732906

Citations 66

Authors

Jie Lin

Yohei Horikawa

Pheroze Tamboli

Jessica Clague

Christopher G Wood

Xifeng Wu

Affiliations

Soon will be listed here.

Abstract

We took a polygenic approach to evaluate the effects of 41 potentially functional single-nucleotide polymorphisms (SNPs) in microRNAs (miRNAs)-related genes on survival and recurrence among renal cell carcinoma (RCC) patients. During a median follow-up of 21.8 months, among 316 RCC patients, 64 died and 56 developed recurrence. In single-SNP analysis, we identified seven SNPs significantly associated with RCC survival and five SNPs with recurrence. The most significant associations were SNPs in GEMIN4 with the variant alleles of both rs7813 and rs910925 associated with 1.74-fold [95% confidence interval (CI) = 1.15-2.62] increased risk of death, whereas the variant allele of rs3744741 conferred a decreased risk of death [hazard ratio (HR) = 0.39; 95% CI = 0.19-0.77]. Several SNPs belonging to the pre-miRNA and were identified to be significantly associated with RCC recurrence. Haplotypes of DICER and DROSHA were also associated with altered patient survival and recurrence. More importantly, we observed cumulative effects of multiple SNPs on RCC survival. Compared with subjects carrying zero to two unfavorable genotypes, those carrying three to five and six and more unfavorable genotypes had an increased risk of death with a HR of 2.49 (95% CI = 1.24-5.00) and 6.66 (95% CI = 2.49-17.86), respectively, with significant dose-response trend (P for trend<0.001). As the first study of miRNA-related genetic polymorphisms on RCC clinical outcome, our results strongly suggested that miRNA-related SNPs may impact the recurrence and survival in RCC patients. Future investigation in larger populations and functional characterizations are necessary to validate these results.

Citing Articles

Genetic Variation in MiRNA Processing Machinery Genes and Susceptibility to Colorectal Cancer in the Iranian Population.

Mobaraki M, Aghdaei H, Angaji S, Nazemalhosseini-Mojarad E, Arbabian S Iran J Public Health. 2025; 53(12):2812-2822.

PMID: 39759214 PMC: 11693808.

Gene Variants in Components of the microRNA Processing Pathway in Chronic Myeloid Leukemia.

Chavaro-Francisco G, Hernandez-Zavala A, Bravo-Cidro C, Rios-Rodriguez S, Mucino-Sanchez M, Lopez-Lopez M Genes (Basel). 2024; 15(8).

PMID: 39202414 PMC: 11353722. DOI: 10.3390/genes15081054.

Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.

Liu S, Yan Y, Cui Z, Feng H, Zhong F, Liu Z BMC Cancer. 2023; 23(1):1149.

PMID: 38012622 PMC: 10680212. DOI: 10.1186/s12885-023-11651-2.

Genetic Variation in DEAD-Box Helicase 20 as a Putative Marker of Recurrence in Propensity-Matched Colon Cancer Patients.

Hobani Y, Almars A, Alelwani W, Toraih E, Nemr N, Shaalan A Genes (Basel). 2022; 13(8).

PMID: 36011315 PMC: 9407271. DOI: 10.3390/genes13081404.

Rs6757 in microRNA-3976 binding site of CD147 confers risk of hepatocellular carcinoma in South Chinese population.

Guo F, Li H, Wang L, Song X, Wang J, Feng Q World J Surg Oncol. 2022; 20(1):260.

PMID: 35978360 PMC: 9382786. DOI: 10.1186/s12957-022-02724-w.

References

Calin G, Liu C, Sevignani C, Ferracin M, Felli N, Dumitru C . MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A. 2004; 101(32):11755-60. PMC: 511048. DOI: 10.1073/pnas.0404432101. View

Shpargel K, Matera A . Gemin proteins are required for efficient assembly of Sm-class ribonucleoproteins. Proc Natl Acad Sci U S A. 2005; 102(48):17372-7. PMC: 1297697. DOI: 10.1073/pnas.0508947102. View

Zhang L, Huang J, Yang N, Greshock J, Megraw M, Giannakakis A . microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A. 2006; 103(24):9136-41. PMC: 1474008. DOI: 10.1073/pnas.0508889103. View

Maru D, Singh R, Hannah C, Albarracin C, Li Y, Abraham R . MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol. 2009; 174(5):1940-8. PMC: 2671281. DOI: 10.2353/ajpath.2009.080718. View

Williams A, Perry M, Moschos S, Larner-Svensson H, Lindsay M . Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans. 2008; 36(Pt 6):1211-5. DOI: 10.1042/BST0361211. View

Wan D, He M, Wang J, Qiu X, Zhou W, Luo Z . Two variants of the human hepatocellular carcinoma-associated HCAP1 gene and their effect on the growth of the human liver cancer cell line Hep3B. Genes Chromosomes Cancer. 2003; 39(1):48-58. DOI: 10.1002/gcc.10293. View

Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell J . Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology. 2006; 130(7):2113-29. DOI: 10.1053/j.gastro.2006.02.057. View

Yue J, Tigyi G . MicroRNA trafficking and human cancer. Cancer Biol Ther. 2006; 5(6):573-8. DOI: 10.4161/cbt.5.6.2872. View

Escudier B . Advanced renal cell carcinoma: current and emerging management strategies. Drugs. 2007; 67(9):1257-64. DOI: 10.2165/00003495-200767090-00002. View

10.

Yang H, Dinney C, Ye Y, Zhu Y, Grossman H, Wu X . Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res. 2008; 68(7):2530-7. DOI: 10.1158/0008-5472.CAN-07-5991. View

11.

MacRae I, Zhou K, Doudna J . Structural determinants of RNA recognition and cleavage by Dicer. Nat Struct Mol Biol. 2007; 14(10):934-40. DOI: 10.1038/nsmb1293. View

12.

Lim L, Lau N, Garrett-Engele P, Grimson A, Schelter J, Castle J . Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005; 433(7027):769-73. DOI: 10.1038/nature03315. View

13.

Kawanami D, Mahabeleshwar G, Lin Z, Atkins G, Hamik A, Haldar S . Kruppel-like factor 2 inhibits hypoxia-inducible factor 1alpha expression and function in the endothelium. J Biol Chem. 2009; 284(31):20522-30. PMC: 2742816. DOI: 10.1074/jbc.M109.025346. View

14.

Shen J, Ambrosone C, Dicioccio R, Odunsi K, Lele S, Zhao H . A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis. 2008; 29(10):1963-6. DOI: 10.1093/carcin/bgn172. View

15.

Hurst D, Edmonds M, Scott G, Benz C, Vaidya K, Welch D . Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009; 69(4):1279-83. PMC: 2754225. DOI: 10.1158/0008-5472.CAN-08-3559. View

16.

Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K . Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 2005; 96(2):111-5. PMC: 11158408. DOI: 10.1111/j.1349-7006.2005.00015.x. View

17.

Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M . Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006; 9(3):189-98. DOI: 10.1016/j.ccr.2006.01.025. View

18.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View

19.

Janzen N, Kim H, Figlin R, Belldegrun A . Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003; 30(4):843-52. DOI: 10.1016/s0094-0143(03)00056-9. View

20.

Merritt W, Lin Y, Han L, Kamat A, Spannuth W, Schmandt R . Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med. 2008; 359(25):2641-50. PMC: 2710981. DOI: 10.1056/NEJMoa0803785. View